{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:14:11Z","timestamp":1783498451573,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00415-026-13959-y","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:44:51Z","timestamp":1782143091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of intravenous thrombolysis in patients with acute ischemic stroke and direct oral anticoagulant use within 1 day before stroke onset"],"prefix":"10.1007","volume":"273","author":[{"given":"Chia-Lin","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jie","family":"Jhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jheng-Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Chi","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0071-9069","authenticated-orcid":false,"given":"Tou-Yuan","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"13959_CR1","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(10)60491-6","volume":"375","author":"KR Lees","year":"2010","unstructured":"Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375:1695\u20131703","journal-title":"Lancet"},{"key":"13959_CR2","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association\/American stroke association. Stroke 50:e344\u2013e418","journal-title":"Stroke"},{"key":"13959_CR3","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/2396987321989865","volume":"6","author":"E Berge","year":"2021","unstructured":"Berge E, Whiteley W, Audebert H, De Marchis G, Fonseca AC, Padiglioni C, P\u00e9rez de la Ossa N, Strbian D, Tsivgoulis G, Turc G (2021) European stroke organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J 6:I\u2013LXII","journal-title":"Eur Stroke J"},{"key":"13959_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/str.0000000000000513","author":"S Prabhakaran","year":"2026","unstructured":"Prabhakaran S, Gonzalez NR, Zachrison KS, Adeoye O, Alexandrov AW, Ansari SA, Chapman S, Czap AL, Dumitrascu OM, Ishida K, Jadhav AP, Johnson B, Johnston KC, Khatri P, Kimberly WT, Lee VH, Leslie-Mazwi TM, Mac Grory B, Madsen TE, Menon B, Mistry EA, Park S, Parker S, P\u00e9rez de la Ossa N, Reeves M, Saiz T, Scott PA, Schwartzberg D, Sheth SA, Sporns PB, Times S, Tjoumakaris S, Wolfe SQ, Yaghi S (2026) 2026 Guideline for the early management of patients with acute ischemic stroke: a guideline from the American heart association\/American stroke association. Stroke. https:\/\/doi.org\/10.1161\/str.0000000000000513","journal-title":"Stroke"},{"key":"13959_CR5","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/jama.2022.0948","volume":"327","author":"W Kam","year":"2022","unstructured":"Kam W, Holmes DN, Hernandez AF, Saver JL, Fonarow GC, Smith EE, Bhatt DL, Schwamm LH, Reeves MJ, Matsouaka RA, Khan YM, Unverdorben M, Birmingham MC, Lyden PD, Asimos AW, Altschul D, Schoonover TL, Jumaa MA, Nomura JT, Suri MFK, Moore SA, Lafranchise EF, Olson D, Peterson ED, Xian Y (2022) Association of recent use of non-vitamin K antagonist oral anticoagulants with intracranial hemorrhage among patients with acute ischemic stroke treated with alteplase. JAMA 327:760\u2013771","journal-title":"JAMA"},{"key":"13959_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025809","volume":"11","author":"T Okada","year":"2022","unstructured":"Okada T, Yoshimoto T, Wada S, Yoshimura S, Chiba T, Egashira S, Kimura S, Shiozawa M, Inoue M, Ihara M, Toyoda K, Takashima H, Koga M (2022) Intravenous thrombolysis with alteplase at 0.6\u2009mg\/kg in patients with ischemic stroke taking direct oral anticoagulants. J Am Heart Assoc 11:e025809","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"13959_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/jamaneurol.2022.4782","volume":"80","author":"TR Meinel","year":"2023","unstructured":"Meinel TR, Wilson D, Gensicke H, Scheitz JF, Ringleb P, Goganau I, Kaesmacher J, Bae H-J, Kim DY, Kermer P, Suzuki K, Kimura K, Macha K, Koga M, Wada S, Altersberger V, Salerno A, Palanikumar L, Zini A, Forlivesi S, Kellert L, Wischmann J, Kristoffersen E, Beharry J, Barber PA, Hong JB, Cereda C, Schlemm E, Yakushiji Y, Poli S, Leker R, Romoli M, Zedde M, Curtze S, Ikenberg B, Uphaus T, Giannandrea D, Portela PC, Veltkamp R, Ranta A, Arnold M, Fischer U, Cha J-K, Wu TY, Purrucker JC, Seiffge DJ, International DOAC-IVT T, Collaboration C-K-N, Group D-IW (2023) Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants. JAMA Neurol 80(3):233\u2013243","journal-title":"JAMA Neurol"},{"key":"13959_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jamainternmed.2023.6160","volume":"184","author":"T-Y Tsai","year":"2024","unstructured":"Tsai T-Y, Liu Y-C, Huang W-T, Tu Y-K, Qiu S-Q, Noor S, Huang Y-C, Chou EH, Lai EC-C, Huang H-K (2024) Risk of bleeding following non-vitamin K antagonist oral anticoagulant use in patients with acute ischemic stroke treated with alteplase. JAMA Intern Med 184:37\u201345","journal-title":"JAMA Intern Med"},{"key":"13959_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40560-016-0144-5","volume":"4","author":"M Ieko","year":"2016","unstructured":"Ieko M, Naitoh S, Yoshida M, Takahashi N (2016) Profiles of direct oral anticoagulants and clinical usage-dosage and dose regimen differences. J Intensive Care 4:19","journal-title":"J Intensive Care"},{"issue":"6","key":"13959_CR10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/ana.27189","volume":"97","author":"M Matusevicius","year":"2025","unstructured":"Matusevicius M, S\u00e4flund M, Balestrino M, Cappellari M, Ferrandi D, Ghoreishi A, Peeters A, Rand VM, De Michele M, Vilionskis A, Zini A, Ahmed N (2025) Intravenous thrombolysis in patients taking direct oral anticoagulation treatment before stroke onset: results from the safe implementations of treatments in stroke international stroke registry. Ann Neurol 97(6):1205\u20131214","journal-title":"Ann Neurol"},{"key":"13959_CR11","unstructured":"(2024) Safety and efficacy of intravenous thrombolysis in patients with ischemic stroke on treatment with direct oral anticoagulants: DO-IT - The DOAC Intravenous thrombolysis trial. In:. https:\/\/clinicaltrials.gov\/study\/NCT06571149"},{"key":"13959_CR12","unstructured":"(2025) The Efficacy and safety of intravenous thrombolysis in acute ischemic stroke patients with recent ingestion of factor Xa-inhibitors trial (SIFT). In: Klinbeforsk, Clinical trial unit OUH (eds). https:\/\/clinicaltrials.gov\/study\/NCT06878066"},{"key":"13959_CR13","unstructured":"(2024) A Multicentre, prospective, randomized, open label, blinded-endpoint trial to optimize the use of intravenous tenecteplase in participants with acute ischemic stroke (ACT-GLOBAL THROMBOLYSIS (ACT WHEN-001) Within a Multi-faCtorial, MulTi-arm, Multi-staGe, Randomised, GLOBal Adaptive PLatform trial for stroke (ACT-GLOBAL) NCT06352632. In: The George Institute for Global Health A (ed). https:\/\/clinicaltrials.gov\/study\/NCT06320431?cond=NCT06320431&rank=1"},{"key":"13959_CR14","doi-asserted-by":"publisher","first-page":"1516126","DOI":"10.3389\/fphar.2025.1516126","volume":"16","author":"RJ Ludwig","year":"2025","unstructured":"Ludwig RJ, Anson M, Zirpel H, Thaci D, Olbrich H, Bieber K, Kridin K, Dempfle A, Curman P, Zhao SS, Alam U (2025) A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX. Front Pharmacol 16:1516126","journal-title":"Front Pharmacol"},{"key":"13959_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooad035","volume":"6","author":"MB Palchuk","year":"2023","unstructured":"Palchuk MB, London JW, Perez-Rey D, Drebert ZJ, Winer-Jones JP, Thompson CN, Esposito J, Claerhout B (2023) A global federated real-world data and analytics platform for research. JAMIA Open 6:ooad035","journal-title":"JAMIA Open"},{"key":"13959_CR16","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1001\/jamaophthalmol.2023.4716","volume":"141","author":"KM Wai","year":"2023","unstructured":"Wai KM, Knapp A, Ludwig CA, Koo E, Parikh R, Rahimy E, Mruthyunjaya P (2023) Risk of stroke, myocardial infarction, and death after retinal artery occlusion. JAMA Ophthalmol 141:1110\u20131116","journal-title":"JAMA Ophthalmol"},{"key":"13959_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/jamaneurol.2024.2057","volume":"81","author":"EK Acton","year":"2024","unstructured":"Acton EK, Hennessy S, Gelfand MA, Leonard CE, Bilker WB, Shu D, Willis AW, Kasner SE (2024) Direct-acting oral anticoagulants and antiseizure medications for atrial fibrillation and epilepsy and risk of thromboembolic events. JAMA Neurol 81:835\u2013844","journal-title":"JAMA Neurol"},{"key":"13959_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","volume":"156","author":"AA Ghaferi","year":"2021","unstructured":"Ghaferi AA, Schwartz TA, Pawlik TM (2021) STROBE reporting guidelines for observational studies. JAMA Surg 156:577\u2013578","journal-title":"JAMA Surg"},{"key":"13959_CR19","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1161\/STROKEAHA.107.490896","volume":"38","author":"H Ay","year":"2007","unstructured":"Ay H, Benner T, Arsava EM, Furie KL, Singhal AB, Jensen MB, Ayata C, Towfighi A, Smith EE, Chong JY, Koroshetz WJ, Sorensen AG (2007) A computerized algorithm for etiologic classification of ischemic stroke: the causative classification of stroke system. Stroke 38:2979\u20132984","journal-title":"Stroke"},{"key":"13959_CR20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1159\/000210433","volume":"27","author":"P Amarenco","year":"2009","unstructured":"Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG (2009) New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis 27:502\u2013508","journal-title":"Cerebrovasc Dis"},{"issue":"8","key":"13959_CR21","doi-asserted-by":"publisher","first-page":"2008150","DOI":"10.1161\/JAHA.117.008150","volume":"7","author":"YH Chan","year":"2018","unstructured":"Chan YH, See LC, Tu HT, Yeh YH, Chang SH, Wu LS, Lee HF, Wang CL, Kuo CF, Kuo CT (2018) Efficacy and safety of apixaban, dabigatran, rivaroxaban, and warfarin in asians with nonvalvular atrial fibrillation. J Am Heart Assoc 7(8):2008150","journal-title":"J Am Heart Assoc"},{"key":"13959_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/CLEP.S288518","volume":"13","author":"M-T Hsieh","year":"2021","unstructured":"Hsieh M-T, Huang K-C, Hsieh C-Y, Tsai T-T, Chen L-C, Sung S-F (2021) Validation of ICD-10-CM diagnosis codes for identification of patients with acute hemorrhagic stroke in a national health insurance claims database. Clin Epidemiol 13:43\u201351","journal-title":"Clin Epidemiol"},{"key":"13959_CR23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.6424","volume":"3","author":"CT Tsai","year":"2020","unstructured":"Tsai CT, Liao JN, Chiang CE, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chung FP, Chao TF, Lip GYH, Chen SA (2020) Association of ischemic stroke, major bleeding, and other adverse events with warfarin use vs non-vitamin K antagonist oral anticoagulant use in patients with atrial fibrillation with a history of intracranial hemorrhage. JAMA Netw Open 3:e206424","journal-title":"JAMA Netw Open"},{"key":"13959_CR24","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/aje\/kwy049","volume":"187","author":"SV Wang","year":"2018","unstructured":"Wang SV, Jin Y, Fireman B, Gruber S, He M, Wyss R, Shin H, Ma Y, Keeton S, Karami S, Major JM, Schneeweiss S, Gagne JJ (2018) Relative performance of propensity score matching strategies for subgroup analyses. Am J Epidemiol 187:1799\u20131807","journal-title":"Am J Epidemiol"},{"key":"13959_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12959-022-00394-y","volume":"20","author":"JH Chen","year":"2022","unstructured":"Chen JH, Hong CT, Chung CC, Kuan YC, Chan L (2022) Safety and efficacy of endovascular thrombectomy in acute ischemic stroke treated with anticoagulants: a systematic review and meta-analysis. Thromb J 20:35","journal-title":"Thromb J"},{"key":"13959_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/jnr.23302","volume":"92","author":"S Kono","year":"2014","unstructured":"Kono S, Deguchi K, Omote Y, Yunoki T, Yamashita T, Kurata T, Ikeda Y, Abe K (2014) Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat. J Neurosci Res 92:46\u201353","journal-title":"J Neurosci Res"},{"key":"13959_CR27","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/STROKEAHA.114.005316","volume":"45","author":"S Kono","year":"2014","unstructured":"Kono S, Yamashita T, Deguchi K, Omote Y, Yunoki T, Sato K, Kurata T, Hishikawa N, Abe K (2014) Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat. Stroke 45:2404\u20132410","journal-title":"Stroke"},{"key":"13959_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/jcbfm.2013.226","volume":"34","author":"R Ploen","year":"2014","unstructured":"Ploen R, Sun L, Zhou W, Heitmeier S, Zorn M, Jenetzky E, Veltkamp R (2014) Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke. J Cereb Blood Flow Metab 34:495\u2013501","journal-title":"J Cereb Blood Flow Metab"},{"key":"13959_CR29","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1161\/STROKEAHA.117.016720","volume":"48","author":"AD Barreto","year":"2017","unstructured":"Barreto AD, Ford GA, Shen L, Pedroza C, Tyson J, Cai C, Rahbar MH, Grotta JC, Ajani Z, Alexandrov AV, Cherches I, Coull B, Dawson J, del Junco D, Demchuk A, Devine J, Dickerson AS, Dixit A, Frey JL, James M, Khan U, Levine S, MacDonald C, Malkoff M, McColl E, Misra V, Mullen M, Perry R, Piechowski-Jozwiak B, Roffe C, Sangha N, Sisson A, Tsivgoulis G, Volpi JJ (2017) Randomized, multicenter trial of ARTSS-2 (Argatroban with recombinant tissue plasminogen activator for acute stroke). Stroke 48:1608\u20131616","journal-title":"Stroke"},{"key":"13959_CR30","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.04.002","volume":"25","author":"J Shang","year":"2016","unstructured":"Shang J, Yamashita T, Kono S, Morihara R, Nakano Y, Fukui Y, Li X, Hishikawa N, Ohta Y, Abe K (2016) Effects of pretreatment with warfarin or rivaroxaban on neurovascular unit dissociation after tissue plasminogen activator thrombolysis in ischemic rat brain. J Stroke Cerebrovasc Dis 25:1997\u20132003","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"13959_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189893","author":"M Bieber","year":"2021","unstructured":"Bieber M, Foerster KI, Haefeli WE, Pham M, Schuhmann MK, Kraft P (2021) Treatment with edoxaban attenuates acute stroke severity in mice by reducing blood-brain barrier damage and inflammation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22189893","journal-title":"Int J Mol Sci"},{"key":"13959_CR32","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009507","volume":"7","author":"Y Sakamoto","year":"2018","unstructured":"Sakamoto Y, Okubo S, Sekine T, Nito C, Suda S, Matsumoto N, Nishiyama Y, Aoki J, Shimoyama T, Kanamaru T, Suzuki K, Mishina M, Kimura K (2018) Prior direct oral anticoagulant therapy is related to small infarct volume and no major artery occlusion in patients with stroke and non-valvular atrial fibrillation. J Am Heart Assoc 7:e009507","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"13959_CR33","doi-asserted-by":"publisher","first-page":"e003074","DOI":"10.1161\/JAHA.115.003074","volume":"5","author":"X Yao","year":"2016","unstructured":"Yao X, Abraham NS, Alexander GC, Crown W, Montori VM, Sangaralingham LR, Gersh BJ, Shah ND, Noseworthy PA (2016) Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation. J Am Heart Assoc 5(2):e003074","journal-title":"J Am Heart Assoc"},{"key":"13959_CR34","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/heartjnl-2020-317887","volume":"107","author":"LA Garc\u00eda Rodr\u00edguez","year":"2020","unstructured":"Garc\u00eda Rodr\u00edguez LA, Cea Soriano L, Munk Hald S, Hallas J, Balabanova Y, Brobert G, Vora P, Sharma M, Gaist D (2020) Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke. Heart 107:542\u2013548","journal-title":"Heart"},{"key":"13959_CR35","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/CIRCULATIONAHA.116.023940","volume":"135","author":"Y Xian","year":"2017","unstructured":"Xian Y, Federspiel JJ, Hernandez AF, Laskowitz DT, Schwamm LH, Bhatt DL, Smith EE, Fonarow GC, Peterson ED (2017) Use of intravenous recombinant tissue plasminogen activator in patients with acute ischemic stroke who take non-vitamin K antagonist oral anticoagulants before stroke. Circulation 135:1024\u20131035","journal-title":"Circulation"},{"key":"13959_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5058","volume":"359","author":"JA L\u00f3pez-L\u00f3pez","year":"2017","unstructured":"L\u00f3pez-L\u00f3pez JA, Sterne JAC, Thom HHZ, Higgins JPT, Hingorani AD, Okoli GN, Davies PA, Bodalia PN, Bryden PA, Welton NJ, Hollingworth W, Caldwell DM, Savovi\u0107 J, Dias S, Salisbury C, Eaton D, Stephens-Boal A, Sofat R (2017) Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. BMJ 359:j5058","journal-title":"BMJ"},{"key":"13959_CR37","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/jamainternmed.2025.1109","volume":"185","author":"S Bea","year":"2025","unstructured":"Bea S, Iyer GS, Kim DH, Lin KJ, Zhang Y, Zakoul H, Tesfaye H, Bykov K (2025) Oral anticoagulation and risk of adverse clinical outcomes in venous thromboembolism. JAMA Intern Med 185:837\u2013846","journal-title":"JAMA Intern Med"},{"key":"13959_CR38","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1001\/jamainternmed.2024.0097","volume":"184","author":"T-Y Tsai","year":"2024","unstructured":"Tsai T-Y, Liu Y-C, Huang H-K (2024) Inconclusive findings in non-vitamin K antagonist oral anticoagulants study\u2014in reply. JAMA Intern Med 184:584\u2013585","journal-title":"JAMA Intern Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13959-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13959-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13959-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:21:17Z","timestamp":1783495277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13959-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["13959"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13959-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The protocol was approved by Institutional Review Board of Dalin Tzu Chi Hospital (No. B11402032, approval date: May, 29th, 2025) in accordance with the Research Involving Human Subjects in Taiwan.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}}],"article-number":"411"}}